Sage Therapeutics Inc. (SAGE)
NASDAQ: SAGE
· Real-Time Price · USD
8.68
0.00 (0.00%)
At close: Jul 30, 2025, 3:59 PM
Sage Therapeutics Revenue
Sage Therapeutics reported an annual revenue of $41.24M, reflecting a -52.3% growth. For the quarter ending June 30, 2025, Sage Therapeutics generated $31.66M in revenue.
Revenue (ttm)
41.24M
Revenue Growth
-52.3%
Price / Sales Ratio
8
Revenue / Employee
116.84K
Employees
353
Market Cap
544.94M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 41.24M | -52.30% |
| Dec 31, 2023 | 86.45M | +1024.84% |
| Dec 31, 2022 | 7.69M | +21.85% |
| Dec 31, 2021 | 6.31M | -99.43% |
| Dec 31, 2020 | 1.11B | +16123.06% |
| Dec 31, 2019 | 6.87M | -92.39% |
| Dec 31, 2018 | 90.27M | +Infinity% |
| Dec 31, 2017 | 0 | n/a |
| Dec 31, 2016 | 0 | n/a |
| Dec 31, 2015 | 0 | n/a |
| Dec 31, 2014 | 0 | n/a |
| Dec 31, 2013 | 0 | n/a |
| Dec 31, 2012 | 0 | n/a |